|
| |
|
 |
| |
| Oncology Product Research |
Pre-
Clinical |
IND
Filing |
Phase
1 |
Phase
2 |
Phase
3
| FDA
Appr-oval
| Phase
4 |
| GROWTH
FACTOR BLOCKERS |
| Flt-3 MAb |
 |
 |
 |
 |
 |
 |
 |
|
INDICATION: AML, ALL
|
| VEGFR-3 MAb |
 |
 |
 |
 |
 |
 |
 |
|
INDICATION: Solid tumors
|
| VE-cadherin MAb |
 |
 |
 |
 |
 |
 |
 |
|
INDICATION: Solid tumors
|
| FGFR MAb |
 |
 |
 |
 |
 |
 |
 |
|
INDICATION: Solid tumors
|
| Ron MAb |
 |
 |
 |
 |
 |
 |
 |
|
INDICATION: Solid tumors
|
| TRP-1 MAb |
 |
 |
 |
 |
 |
 |
 |
|
INDICATION: Solid tumors
|
| PDGFRß MAb |
 |
 |
 |
 |
 |
 |
 |
|
INDICATION: Solid tumors
|
| Neuropilin MAb |
 |
 |
 |
 |
 |
 |
 |
|
INDICATION: Solid tumors
|
|
|